LU87087A1 - Compositions pharmaceutiques contenant des pyranoquinoleines - Google Patents

Compositions pharmaceutiques contenant des pyranoquinoleines Download PDF

Info

Publication number
LU87087A1
LU87087A1 LU87087A LU87087A LU87087A1 LU 87087 A1 LU87087 A1 LU 87087A1 LU 87087 A LU87087 A LU 87087A LU 87087 A LU87087 A LU 87087A LU 87087 A1 LU87087 A1 LU 87087A1
Authority
LU
Luxembourg
Prior art keywords
solution
pharmaceutical composition
composition according
preservative
viscosity
Prior art date
Application number
LU87087A
Other languages
English (en)
French (fr)
Inventor
A R Clark
P Dr Wright
J H Dr Ratcliffe
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630767A external-priority patent/GB8630767D0/en
Priority claimed from GB868630769A external-priority patent/GB8630769D0/en
Priority claimed from GB868630904A external-priority patent/GB8630904D0/en
Priority claimed from GB878706684A external-priority patent/GB8706684D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of LU87087A1 publication Critical patent/LU87087A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
LU87087A 1986-12-23 1987-12-22 Compositions pharmaceutiques contenant des pyranoquinoleines LU87087A1 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB868630767A GB8630767D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB8630767 1986-12-23
GB8630769 1986-12-23
GB868630769A GB8630769D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB8630904 1986-12-24
GB868630904A GB8630904D0 (en) 1986-12-24 1986-12-24 Pharmaceutical formulation
GB8706684 1987-03-20
GB878706684A GB8706684D0 (en) 1987-03-20 1987-03-20 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
LU87087A1 true LU87087A1 (fr) 1989-07-07

Family

ID=27449862

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87087A LU87087A1 (fr) 1986-12-23 1987-12-22 Compositions pharmaceutiques contenant des pyranoquinoleines

Country Status (22)

Country Link
US (1) US5443833A (de)
EP (1) EP0279121B1 (de)
JP (2) JP2568233B2 (de)
KR (1) KR960001370B1 (de)
AU (1) AU595969B2 (de)
BE (2) BE1002179A5 (de)
CA (1) CA1296635C (de)
CH (1) CH674937A5 (de)
DE (1) DE3787274T2 (de)
DK (1) DK175032B1 (de)
ES (1) ES2058129T3 (de)
FI (1) FI875616A (de)
FR (1) FR2609392B1 (de)
GR (1) GR871999B (de)
IE (3) IE63213B1 (de)
IL (1) IL84893A (de)
LU (1) LU87087A1 (de)
MY (1) MY101535A (de)
NO (1) NO875359L (de)
NZ (1) NZ223026A (de)
PT (1) PT86455B (de)
SA (1) SA90110074B1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
EP0294914A3 (de) * 1987-03-17 1990-10-10 FISONS plc Nedocromil zur Behandlung von dermatologischen Krankheiten
GB8727590D0 (en) * 1987-11-25 1987-12-31 Fisons Plc Formulation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
WO2011068721A1 (en) * 2009-12-03 2011-06-09 Opko Health, Inc. Hypersulfated disaccharide formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them
ZA782473B (en) * 1977-05-04 1979-04-25 Fisons Ltd Benzo pyrano-quinolinones
US4474787A (en) * 1977-05-04 1984-10-02 Fisons Limited 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
EP0030423B1 (de) * 1979-12-07 1985-02-13 FISONS plc Verfahren zur Herstellung von 1,4-Dihydro-4-oxo-chinolin-2-carbonsäuren oder Salzen, Estern oder Amiden davon und Zwischenverbindungen dafür
AU8468782A (en) * 1981-06-25 1983-01-06 Fisons Plc Compounds with sodium cromoglycate activity
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
DE3584580D1 (de) * 1984-04-13 1991-12-12 Fisons Plc Formen und formulierungen des nedocromil-natriumsalzes.
GB8630419D0 (en) * 1986-12-19 1987-01-28 Fisons Plc Pharmaceutical formulation
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
EP0294914A3 (de) * 1987-03-17 1990-10-10 FISONS plc Nedocromil zur Behandlung von dermatologischen Krankheiten

Also Published As

Publication number Publication date
IL84893A0 (en) 1988-06-30
DE3787274D1 (de) 1993-10-07
ES2058129T3 (es) 1994-11-01
IE873507L (en) 1988-06-23
DE3787274T2 (de) 1994-01-27
BE1002179A5 (fr) 1990-10-02
IE63213B1 (en) 1995-04-05
JP2568233B2 (ja) 1996-12-25
US5443833A (en) 1995-08-22
PT86455A (en) 1988-01-01
FR2609392A1 (fr) 1988-07-15
CA1296635C (en) 1992-03-03
IL84893A (en) 1991-11-21
NO875359D0 (no) 1987-12-21
FI875616A0 (fi) 1987-12-21
AU8292987A (en) 1988-06-23
GR871999B (en) 1988-04-26
BE1003466A3 (fr) 1992-03-31
FI875616A (fi) 1988-06-24
AU595969B2 (en) 1990-04-12
JPS63233918A (ja) 1988-09-29
NZ223026A (en) 1989-09-27
IE940372L (en) 1988-06-23
EP0279121A2 (de) 1988-08-24
EP0279121B1 (de) 1993-09-01
EP0279121A3 (en) 1990-09-12
PT86455B (pt) 1990-11-20
JP2504926B2 (ja) 1996-06-05
JPH07231926A (ja) 1995-09-05
KR880007082A (ko) 1988-08-26
DK175032B1 (da) 2004-05-03
KR960001370B1 (ko) 1996-01-26
MY101535A (en) 1991-11-30
SA90110074B1 (ar) 2006-03-06
CH674937A5 (de) 1990-08-15
DK680787A (da) 1988-06-24
NO875359L (no) 1988-06-24
IE940371L (en) 1988-06-23
FR2609392B1 (fr) 1994-04-08
DK680787D0 (da) 1987-12-22

Similar Documents

Publication Publication Date Title
FR2588189A1 (fr) Composition pharmaceutique de type a transition de phase liquide-gel
JP2010513366A (ja) 眼科用薬物の輸送に有用なゲル
JP5177446B2 (ja) 低粘度グリコサミノグリカンで構成される組成物及び該組成物の間質性膀胱炎の治療での使用
HU207950B (en) Process for producing pharmaceutical eye-drop composition
FR2688405A1 (fr) Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
FR2573652A1 (fr) Composition aqueuse de cromoglycate de sodium
EP0594770B1 (de) Oxicam und oxicamderivate enthaltende ophthalmische zusammensetzungen
FR2660193A1 (fr) Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules.
LU87615A1 (fr) Solution pharmaceutique
LU87087A1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
BE1005196A0 (fr) Compositions pharmaceutiques aqueuses de cromoglycate sodique.
JP5258329B2 (ja) プラノプロフェン含有水性医薬組成物
JP5019923B2 (ja) プラノプロフェン含有医薬組成物
USRE38628E1 (en) Pharmaceutical compositions
BE1005615A3 (fr) Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
EP0323762B1 (de) Hustenstillende Zusammensetzungen und ein Verfahren zu deren Herstellung
FR2539994A1 (fr) Nouvelles compositions pharmaceutiques administrables par voie nasale
CH653258A5 (fr) Melange de cromoglycate de sodium et de xylometazoline et procede pour le preparer.
RU2197923C1 (ru) Фармацевтическая композиция для лечения отеков роговицы "осмогель"
EP0555717A1 (de) Pharmazeutische Zusammensetzungen in Form von Nedocromil enthaltenden Lösungen
EP0555718A1 (de) Pharmazeutische Zusammensetzungen in Form von weichen Plastikampullen, die eine Nedocromillösung enthalten
JPH06227988A (ja) 眼科用外用剤